THE SHORT-TERM EFFECTS OF PROPRANOLOL, ATENOLOL AND LABETALOL ON ANTIPYRINE KINETICS IN NORMAL SUBJECTS

被引：25
作者：
DANESHMEND, TK
ROBERTS, CJC
机构：
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1982年 / 13卷 / 06期
关键词：
D O I：
10.1111/j.1365-2125.1982.tb01872.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：817 / 820
页数：4
相关论文
共 15 条
[1]  
ANDREASEN PB, 1974, CLIN PHARMACOL THER, V16, P1059
[2]   INHIBITION OF ANTIPYRINE METABOLISM BY BETA-ADRENOCEPTOR ANTAGONISTS [J].
BAX, NDS ;
LENNARD, MS ;
TUCKER, GT .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (06) :779-784
[3]  
BRODIE BB, 1949, J BIOL CHEM, V179, P25
[4]   PHYSIOLOGICAL AND PHARMACOLOGICAL VARIABILITY IN ESTIMATED HEPATIC BLOOD-FLOW IN MAN [J].
DANESHMEND, TK ;
JACKSON, L ;
ROBERTS, CJC .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (05) :491-496
[5]   METABOLIC CONSEQUENCES OF ATENOLOL AND PROPRANOLOL IN TREATMENT OF ESSENTIAL HYPERTENSION [J].
DAY, JL ;
SIMPSON, N ;
METCALFE, J ;
PAGE, RL .
BRITISH MEDICAL JOURNAL, 1979, 1 (6156) :77-80
[6]  
GRAHAM CF, 1981, NEW ENGL J MED, V304, P1301
[7]   IMPAIRMENT OF ANTIPYRINE CLEARANCE IN HUMANS BY PROPRANOLOL [J].
GREENBLATT, DJ ;
FRANKE, K ;
HUFFMAN, DH .
CIRCULATION, 1978, 57 (06) :1161-1164
[8]   HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND ANTIHYPERTENSIVE DRUGS - OSLO STUDY [J].
HELGELAND, A ;
HJERMANN, I ;
LEREN, P ;
ENGER, S ;
HOLME, I .
BRITISH MEDICAL JOURNAL, 1978, 2 (6134) :403-403
[9]  
HERMANSEN K, 1969, ACTA PHARMACOL TOX, V27, P453
[10]  
LANT A, 1980, TOPICS THERAPEUTICS, V6, P53
12